Introduction
Ivermectin is a widely used medication that has been around for decades. Originally discovered in the late 1970s, this drug earned a reputation as a life-saving treatment for parasitic infections. In fact, the discovery of Ivermectin was so impactful that its developers, Dr. William C. Campbell and Dr. Satoshi Ōmura, were awarded the Nobel Prize in Physiology or Medicine in 2015.
Over the years, Ivermectin has become a critical medicine in global health, especially in controlling diseases like river blindness and lymphatic filariasis. However, beyond its traditional role, Ivermectin has gained attention for its potential new uses, including its role in cancer research.
This blog takes a closer look at Ivermectin for humans, including its dosage, uses, side effects, and cancer studies, so you can understand both the promise and the limitations of this drug.
What is Ivermectin?
Ivermectin belongs to a class of drugs called antiparasitics. It works by paralyzing and killing parasites, making it one of the most effective treatments for various infections caused by worms and other parasites.
-
Discovery: Derived from a microorganism found in soil samples in Japan.
-
Approval: First approved for veterinary use, later approved for humans.
-
Nobel Prize: Recognized as one of the greatest contributions to medicine in the 20th century.
Today, Ivermectin is available in tablets, topical creams, and injectable forms (the latter mainly for animals). Human formulations are strictly regulated, while veterinary versions are not safe for people due to dosage differences and inactive ingredients.
Ivermectin Uses in Humans
Ivermectin is approved by the U.S. FDA and WHO for treating multiple conditions. Its primary uses include:
-
Parasitic Worm Infections
-
Onchocerciasis (river blindness)
-
Strongyloidiasis (intestinal infection)
-
Lymphatic filariasis
-
-
Ectoparasite Infections
-
Scabies (skin infestation by mites)
-
Pediculosis (head lice)
-
-
Off-Label Uses
-
Rosacea (skin condition with redness and bumps)
-
Certain viral infections (studied, but not officially approved)
-
Because of its wide range of benefits, Ivermectin is considered an essential medicine by the World Health Organization.
The FDA highlights important safety guidelines for Ivermectin use in humans.
Ivermectin Dosage for Humans
The dosage of Ivermectin depends on the condition being treated, the patient’s weight, and medical history. It is typically taken as an oral tablet with water on an empty stomach.
Common Dosages
-
Onchocerciasis (river blindness):
150 mcg/kg as a single dose, repeated every 6–12 months. -
Strongyloidiasis:
200 mcg/kg once, sometimes repeated after two weeks. -
Scabies:
200 mcg/kg once, repeated after 1–2 weeks. -
Lice:
200 mcg/kg as a single dose, may be repeated after 9–10 days.
⚠️ Note: Dosages for cancer research or off-label uses are still being studied. There is no approved cancer dosage, and self-medicating with veterinary formulations can be dangerous.
Ivermectin Side Effects
Ivermectin is generally well tolerated, but like any medicine, it comes with potential side effects.
Mild Side Effects
-
Nausea
-
Dizziness
-
Fatigue
-
Rash or itching
-
Diarrhea
Serious Side Effects (Rare)
-
Neurological issues (confusion, seizures)
-
Low blood pressure
-
Liver damage (elevated liver enzymes)
-
Eye problems (when treating river blindness due to dying parasites)
Safety Tip: Side effects are usually dose-related. Using the correct formulation and medical dosage is crucial. Veterinary Ivermectin is not safe for human use.
Ivermectin and Cancer Research
One of the most intriguing developments in recent years is the study of Ivermectin as a potential anti-cancer drug. Scientists are exploring whether this well-known antiparasitic could be repurposed to fight cancer.
Proposed Mechanisms
-
Anti-Tumor Activity: Ivermectin may block the growth of cancer cells.
-
Immune System Boost: Helps the body’s immune system recognize and attack tumors.
-
Cell Death Induction: Triggers apoptosis (programmed cell death) in cancer cells.
-
Microtubule Disruption: Similar to how chemotherapy drugs attack cancer cell structure.
Research Highlights
-
Glioblastoma: Studies show Ivermectin may slow brain tumor growth.
-
Breast Cancer: Potential ability to make cancer cells more sensitive to chemotherapy.
-
Lung Cancer: Early evidence of anti-cancer activity in lab models.
-
Colon Cancer: Shown to disrupt cancer cell signaling pathways.
However, most studies are preclinical (lab or animal studies). Human trials are limited, and no major medical authority has approved Ivermectin for cancer treatment.
Fenbendazole, another repurposed drug for cancer, has also gained global attention.
Ivermectin vs Other Repurposed Drugs (Fenbendazole & Mebendazole)
Ivermectin is not the only antiparasitic gaining attention. Other drugs like Fenbendazole (dog dewormer) and Mebendazole (human dewormer) have also shown potential in cancer studies.
-
Similarities:
-
All are antiparasitic drugs.
-
All interfere with microtubules in parasites and possibly cancer cells.
-
-
Differences:
-
Fenbendazole: Popularized by Joe Tippens’ cancer recovery story.
-
Mebendazole: Already used in humans, showing strong anti-cancer promise.
-
Ivermectin: Focused more on immune modulation and cancer cell death.
-
Some researchers believe that combining these repurposed drugs with traditional therapies could provide synergistic effects, but more studies are needed.
Risks of Self-Medicating with Ivermectin
The rise in online discussions has led some people to try Ivermectin on their own, often using veterinary formulations meant for animals. This can be extremely dangerous.
Risks Include:
-
Incorrect dosage (leading to overdose or underdose)
-
Toxic ingredients in animal formulations
-
Delayed cancer treatment due to reliance on unproven therapies
-
Severe side effects from misuse
While research is promising, it’s important to understand that Ivermectin is not an approved cancer treatment at this time.
Future of Ivermectin in Medicine
Despite controversies, researchers are actively studying Ivermectin for new uses.
-
Cancer Trials: Several clinical trials are underway to test Ivermectin’s anti-cancer properties.
-
Combination Therapy: Potential to enhance chemotherapy or radiotherapy.
-
Global Health: Continued role in fighting parasitic diseases, especially in developing countries.
The future may see Ivermectin being repurposed as part of integrative cancer therapy, but much more evidence is needed before it becomes mainstream.
Conclusion
Ivermectin is a remarkable drug that has saved millions of lives from parasitic diseases. Its potential role in cancer research has sparked hope, but the science is still emerging.
-
Uses: Widely used for parasitic infections.
-
Dosage: Depends on condition; no approved cancer dosage yet.
-
Side Effects: Generally safe, but risks exist.
-
Cancer Research: Promising lab results, limited human studies.
While Ivermectin could one day join the list of repurposed drugs for cancer, it’s too early to call it a proven cancer treatment.
FAQs
1. Can humans safely take Ivermectin?
Yes, when taken in correct medical doses prescribed by professionals.
2. What is the correct dosage of Ivermectin for humans?
It varies by condition (parasites, scabies, lice). Cancer dosage is not established.
3. Does Ivermectin really work against cancer?
Lab studies show promise, but human trials are limited. It’s not officially approved.
4. What are the risks of taking veterinary Ivermectin?
Overdose, toxicity, and harmful additives. Veterinary formulations are unsafe for humans.
5. Is Ivermectin approved for cancer treatment?
No. Research is ongoing, but it’s not approved as a cancer drug.